FRESENIUS KABI DEUTSCHLAND GMBH

It is used in adults who are not candidates for a stem cell transplant to treat high-risk myelodysplastic syndromes (MDS), chronic myelomonocytic leukemia (CMML), and acute myeloid leukemia (AML).

Dosage form: powder for preparation of injectable suspension

ATC: L01BC07

It is used in adults with advanced cancer to prevent serious complications caused by bone metastases (such as fractures, pressure on the bone marrow, or the need for surgery/radiotherapy) and for the treatment of giant cell bone tumor in adults and adolescents whose bones have stopped growing.

Dosage form: solution for injection

ATC: M05BX04

It is used in the treatment of multiple myeloma (a bone marrow cancer) in patients over 18 years of age and for the treatment of mantle cell lymphoma (a lymph node cancer) in patients 18 years of age or older.

Dosage form: powder for solution for injection

ATC: L01XG01

It is used as conditioning treatment before a bone marrow or hematopoietic stem cell transplant. It serves to destroy the original bone marrow.

Dosage form: solution for infusion, concentrate

ATC: L01AB01

It is used to treat osteoporosis in postmenopausal women and in men at increased risk of fractures. It is also indicated for bone loss in men caused by reduced testosterone levels (due to surgery or therapy for prostate cancer) and for bone loss due to prolonged glucocorticoid use in patients at risk of fracture.

Dosage form: solution for injection in pre-filled syringe

ATC: M05BX04

This medicine is prescribed for the treatment of several types of cancer, including breast cancer (advanced or early), certain types of lung cancer (non-small cell), prostate cancer, stomach adenocarcinoma, and head and neck cancer.

Dosage form: solution for infusion, concentrate

ATC: L01CD02

Idacio is a medicine that acts on the immune system and is indicated for the treatment of several inflammatory diseases, including rheumatoid arthritis, psoriatic arthritis, plaque psoriasis, hidradenitis suppurativa, Crohn's disease, ulcerative colitis, non-infectious uveitis, ankylosing spondylitis, and other forms of arthritis.

Dosage form: solution for injection in pre-filled syringe

ATC: L04AB04

It provides energy and omega-3 fatty acids derived from fish oil through the blood when oral feeding is not possible, not sufficient, or not recommended.

Dosage form: emulsion for intravenous infusion

ATC: B05BA02

Otulfi is used for the treatment of certain inflammatory diseases, including plaque psoriasis (in adults and children from 6 years of age), psoriatic arthritis (in adults), and moderate to severe Crohn's disease (in adults and children weighing at least 40 kg).

Dosage form: solution for injection in pre-filled syringe

ATC: L04AC05

It is used for the treatment of certain types of cancer, such as malignant pleural mesothelioma and advanced-stage lung cancer, usually in combination with another drug called cisplatin.

Dosage form: powder for concentrate for infusion solution

ATC: L01BA04

It is used to reduce the duration of neutropenia (low white blood cell count) and the risk of febrile neutropenia that may be caused by chemotherapy. The drug stimulates the bone marrow to produce more white blood cells to help the body fight infections.

Dosage form: solution for injection

ATC: L03AA13

It is used to speed up muscle recovery after surgery, allowing the patient to return to breathing independently as soon as possible. It works by binding to neuromuscular blocking agents (such as rocuronium bromide or vecuronium bromide) administered during general anesthesia.

Dosage form: solution for injection

ATC: V03AB35

Tyenne is used to treat several inflammatory conditions: rheumatoid arthritis (RA) in adults, giant cell arteritis (GCA) in adults, systemic juvenile idiopathic arthritis (sJIA) and polyarticular juvenile idiopathic arthritis (pJIA) in children and adolescents, cytokine release syndrome (CRS), and COVID-19 in patients requiring oxygen or ventilation.

Dosage form: solution for infusion, concentrate

ATC: L04AC07